Available from: Accessed 8 Dec 2024
Arora RP, Nayak RL, Malhotra V, Mohanty NK, Kulkarni SK
Results show that the SU11274 treatment was not associated with any significant alteration in the expression of stem cell markers, but the inhibitor stimulated higher level of pluripotent markers
A deficiency of acid phosphatase activity in the lysosomal fraction, presumably due to impairment of the ACP2 protein, manifests as intermittent vomiting, hypotonia, lethargy, opisthotonos, terminal bleeding and death in early infancy (136)
Hundreds of members have posted protocols, results, and side effects across that time
Diana Doyle-Zebrun is the Clinical and Quality Initiatives Co-ordinator at the Provincial Health Contact Centre at Misericordia Health Centre